Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $829,870 - $987,768
7,263 New
7,263 $893,000
Q4 2022

Feb 13, 2023

BUY
$129.72 - $159.85 $1.19 Million - $1.46 Million
9,153 New
9,153 $1.46 Million
Q4 2021

Feb 11, 2022

SELL
$119.87 - $145.67 $1.54 Million - $1.88 Million
-12,875 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$128.64 - $184.79 $1.66 Million - $2.38 Million
12,875 New
12,875 $1.68 Million
Q2 2021

Aug 12, 2021

SELL
$160.2 - $186.42 $344,430 - $400,803
-2,150 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$150.19 - $173.5 $322,908 - $373,025
2,150 New
2,150 $353,000
Q2 2020

Aug 13, 2020

SELL
$95.68 - $121.88 $13,203 - $16,819
-138 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$87.74 - $152.74 $536,091 - $933,241
-6,110 Reduced 97.79%
138 $13,000
Q4 2019

Feb 10, 2020

BUY
$117.65 - $153.73 $523,071 - $683,483
4,446 Added 246.73%
6,248 $932,000
Q3 2019

Nov 12, 2019

BUY
$125.18 - $143.24 $225,574 - $258,118
1,802 New
1,802 $230,000
Q2 2019

Aug 13, 2019

SELL
$125.55 - $144.48 $509,733 - $586,588
-4,060 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$121.81 - $142.95 $608,684 - $714,321
-4,997 Reduced 55.17%
4,060 $580,000
Q4 2018

Feb 13, 2019

BUY
$115.94 - $166.74 $585,381 - $841,870
5,049 Added 125.97%
9,057 $1.12 Million
Q3 2018

Nov 13, 2018

SELL
$161.01 - $180.57 $195,305 - $219,031
-1,213 Reduced 23.23%
4,008 $673,000
Q2 2018

Aug 13, 2018

BUY
$146.33 - $183.18 $763,988 - $956,382
5,221 New
5,221 $899,000
Q1 2018

May 11, 2018

SELL
$135.59 - $157.16 $560,122 - $649,227
-4,131 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$131.06 - $150.39 $541,408 - $621,261
4,131
4,131 $556,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.